Form 4: Nu Skin Director Emma Battle Reports Stock Transactions Under 10b5-1 Plan

Nu Skin Enterprises Director Emma S. Battle reported the acquisition of 18,008 shares and the sale of 4,532 shares of Class A Common Stock on June 2, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Emma S. Battle, a Director of Nu Skin Enterprises, Inc. (NUS), reported two transactions involving Class A Common Stock on June 2, 2025.
• She acquired 18,008 shares of Class A Common Stock at a price of $0.00 per share, likely as part of an equity grant or award.
• Concurrently, she disposed of 4,532 shares of Class A Common Stock at a price of $8.44 per share.
• Following these transactions, Emma S. Battle beneficially owns 31,006 shares of Class A Common Stock.
• Both transactions were conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan, indicating a pre-scheduled trading activity.
• The filing also includes a Limited Power of Attorney, executed on May 5, 2025, authorizing designated individuals to handle Ms. Battle's SEC reporting obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares at $0.00 indicates an equity grant, which is positive for aligning interests. The sale is a routine insider transaction, likely for tax or liquidity purposes, and does not necessarily indicate negative sentiment towards the company.

Positives

• The acquisition of 18,008 shares at $0.00 indicates an equity grant, which aligns the director's interests with shareholders.
• The transactions were conducted under a Rule 10b5-1 plan, indicating pre-planned and transparent trading activity, reducing concerns about opportunistic insider trading.

Negatives

• The sale of 4,532 shares, even if for tax purposes or liquidity, reduces the director's direct ownership in the company.
• The sale price of $8.44 per share is relatively low, potentially reflecting the current market valuation of Nu Skin's stock.

Risks

• No specific new risks are mentioned in this Form 4 filing itself, beyond the inherent risks associated with holding equity securities.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports routine insider transactions for a director of Nu Skin Enterprises, a direct-selling company specializing in personal care products and dietary supplements. Such transactions are common for corporate executives and directors, often related to equity compensation plans or personal financial planning, and do not inherently reflect broader industry trends or competitive positioning.

Management Changes

Corporate Governance

Legal Proceedings

• The document does not mention any legal proceedings or regulatory matters.

Related Party Transactions

• The reported stock transactions are related-party transactions as they involve a director of the company acquiring and disposing of company stock.

Stakeholder Impact

• Shareholders: The transactions are routine insider filings and do not indicate a significant direct impact on shareholders beyond the transparency of director holdings. The equity grant aligns the director's interests with shareholders.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the routine compliance with SEC reporting requirements.

Key Dates

Recommendation

Keywords

Nu Skin Enterprises, NUS, Form 4, Insider Trading, Stock Transaction, Director, Equity Grant, Stock Sale, 10b5-1 Plan, Emma S. Battle, SEC Filing